NPM1 and acute myeloid leukemia: Use of both qPCR and ddPCR are restricted to well-validated gene mutations or rearrangements: The ELN recommends qPCR for initial MRD assessment in AML patients with NPM1, t(8; 21), inv [16], and t(15;17).